These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21455329)

  • 21. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
    Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
    Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective administration method of intravenous proton pump inhibitor: a novel testing using a BRAVO catheterless pH monitoring system.
    Kım KJ; Park MI; Park SJ; Cho SW; Moon W; Kim GM; Kim WM
    Turk J Gastroenterol; 2011 Dec; 22(6):575-81. PubMed ID: 22287401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Propofol on Acid Reflux Measured with the Bravo pH Monitoring System.
    Chawla A; Girda E; Walker G; Turcotte Benedict F; Tempel M; Morganstern J
    ISRN Gastroenterol; 2013; 2013():605931. PubMed ID: 23691337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bravo capsule induction of esophageal hypercontractility and chest pain.
    Tharavej C; Hagen JA; Portale G; Hsieh CC; Gandamihardja TA; Lipham JC; Peters JH; DeMeester SR; Crookes PF; Bremner CG; DeMeester TR
    Surg Endosc; 2006 May; 20(5):783-6. PubMed ID: 16544080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.
    Ward MA; Dunst CM; Teitelbaum EN; Halpin VJ; Reavis KM; Swanström LL; DeMeester SR
    Surg Endosc; 2018 Feb; 32(2):889-894. PubMed ID: 28779252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two years' experience of using the Bravo wireless oesophageal pH monitoring system at a single UK tertiary centre.
    Rao NM; Campbell DI; Rao P
    Acta Paediatr; 2017 Feb; 106(2):312-315. PubMed ID: 27862298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.
    Ayazi S; Hagen JA; Zehetner J; Banki F; Augustin F; Ayazi A; DeMeester SR; Oh DS; Sohn HJ; Lipham JC; DeMeester TR
    Surg Endosc; 2011 Jul; 25(7):2219-23. PubMed ID: 21359906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sedation and Afternoon Placement of the 48-Hour Wireless Ambulatory pH Capsule Results in More Reflux on the First Day.
    Patel R; Chae S; Kumar A; Richter JE
    J Clin Gastroenterol; 2017 Aug; 51(7):594-598. PubMed ID: 27548735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory pH: monitoring with a wireless system.
    Schneider JH; Kramer KM; Königsrainer A; Granderath FA
    Surg Endosc; 2007 Nov; 21(11):2076-80. PubMed ID: 17484003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.
    Afaneh C; Zoghbi V; Finnerty BM; Aronova A; Kleiman D; Ciecierega T; Crawford C; Fahey TJ; Zarnegar R
    Surg Endosc; 2016 Aug; 30(8):3454-60. PubMed ID: 26537906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
    Jain M; Agrawal V
    Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
    Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal pH testing in patients refractory to proton pump inhibitor therapy.
    Mackalski BA; Ilnyckyj A
    Can J Gastroenterol; 2008 Mar; 22(3):249-52. PubMed ID: 18354753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wireless ambulatory pH studies: manometric or endoscopic guidance?
    Nusrat S; Roy PM; Bielefeldt K
    Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.